(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

MAPLAB

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

MAPLAB

ST13

US500000098188329

Class

35, 42

Filing

98188329

Registration

7616057

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

26

Latest update

12/17/2024

Trademark type

Word

Nice classes

35, 42

Filing date

09/20/2023

Registration date

12/17/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

12/17/2024

Last transaction

12/17/2024

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

09/23/2023

First use in commerce

09/23/2023

Drawing code

4

Owner type

03

Owner location

San Francisco, CA

Examiner

RENNEKER, CHRISTOPHER JOHN

Law office

M40

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Komodo Health, Inc.

Representatives

Jordan A. LaVine FLASTER GREENBERG PC

Technical classification

Nice Classes

Class 35Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 35

Business data collection and analysis services in the field of healthcareaggregatingorganizing and compiling of informationdatastatisticsinsightsmetricsprofilesanalytics and intelligence on healthcare industry demographicspractitioner demographicspatient demographicspatient therapies and treatmentsprescriptionspatient flows and referral pathwaysdisease demographicscare demographicslab dataclinical study and trial demographicshealthcare behaviorscostsoutcomespayer datascientific publicationsall of the foregoing excluding psychedelic medicines and therapies; business consulting and analysis services regarding informationdatastatisticsinsightsmetricsprofilesanalytics and intelligence on healthcare industry demographicspractitioner demographicspatient demographicspatient therapies and treatmentsprescriptionspatient flows and referral pathwaysdisease demographicscare demographicslab dataclinical study and trial demographicshealthcare behaviorscostsoutcomespayer datascientific publicationsall of the foregoing excluding psychedelic medicines and therapies; Providing business information in the field of the healthcare and life sciences industriesall of the foregoing excluding psychedelic medicines and therapies; Business consulting services to businesses in the healthcare and life sciences industriesall of the foregoing excluding psychedelic medicines and therapies

Class 42

Platform-as-a-service (PaaS) featuring computer software platforms that allows organizations and stakeholders in healthcare viewing of a database with informationdatastatisticsinsightsmetricsprofilesanalytics and intelligence on healthcare industry demographicspractitioner demographicspatient demographicspatient therapies and treatmentsprescriptionspatient flows and referral pathwaysdisease demographicscare demographicslab dataclinical study and trial demographicshealthcare behaviorscostsoutcomespayer datascientific publicationsall of the foregoing excluding psychedelic medicines and therapies; platform-as-a-service (PaaS) featuring computer software platforms that allows organizations and stakeholders in healthcare the ability to model patient journeyspathwayscare programsall of the foregoing excluding psychedelic medicines and therapies; computer servicesdatabase development servicesconfiguration and customization of databases containing informationdatastatisticsinsightsmetricsprofilesanalytics and intelligence healthcare industry demographicspractitioner demographicspatient demographicspatient therapies and treatmentsprescriptionspatient flows and referral pathwaysdisease demographicslab datacare demographicsclinical study and trial demographicshealthcare behaviorscostsoutcomespayer datascientific publicationsall of the foregoing excluding psychedelic medicines and therapies; platform-as-a-service (paas) featuring computer software platforms that allow the viewing of market access insights to the life sciences industryprovide business solutions that unify pharmaceutical salesoperationsmarketing dataprovide data intelligence that aids with effective targetingmessaginginitiatives driving sales performanceall of the foregoing excluding psychedelic medicines and therapies; Designdevelopment and implementation of computer software for the healthcare and life sciences industrythe design and development of cloud-based and application-based software for monitoringmarketingdelivering products in the healthcare and life sciences industryall of the foregoing excluding psychedelic medicines and therapies; Consulting services in the fields of selectionimplementation and use of computer hardware and software systems for others in the health care and life science industriesall of the foregoing excluding psychedelic medicines and therapies; Business technology software consultation services in the health care and life science industriesall of the foregoing excluding psychedelic medicines and therapies; Software development and product development consulting in the field of the health care and life science industriesall of the foregoing excluding psychedelic medicines and therapies

Publications

History of USPTO decisions and trademark events.

26 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

12/17/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

12/17/2024

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

11/26/2024

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

11/26/2024

SUPC

STATEMENT OF USE PROCESSING COMPLETE

11/22/2024

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

11/22/2024

IUAF

USE AMENDMENT FILED

09/18/2024

EISU

TEAS STATEMENT OF USE RECEIVED

09/18/2024

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

08/20/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

06/25/2024

PUBO

PUBLISHED FOR OPPOSITION

06/25/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

06/05/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

05/22/2024

ZZZX

PREVIOUS ALLOWANCE COUNT WITHDRAWN

05/22/2024

XAEC

EXAMINER'S AMENDMENT ENTERED

05/22/2024

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

05/22/2024

GNEA

EXAMINERS AMENDMENT E-MAILED

05/22/2024

CNEA

EXAMINERS AMENDMENT -WRITTEN

05/22/2024

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

05/14/2024

GNRT

NON-FINAL ACTION E-MAILED

05/14/2024

CNRT

NON-FINAL ACTION WRITTEN

05/14/2024

DOCK

ASSIGNED TO EXAMINER

05/14/2024

TAEA

TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED

11/01/2023

PARI

TEAS VOLUNTARY AMENDMENT RECEIVED

11/01/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

10/05/2023

NWAP

NEW APPLICATION ENTERED

09/23/2023

Continuous trademark protection

Get notified about every new filing that threatens MAPLAB or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.